Back

Safety and long-term outcomes of heart failure drug minimization in patients with improved ejection fraction: SLIM-HF study

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Treating heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yuxiang Luo

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Impact of TAVR on GDMT in patients with severe aortic stenosis and HFrEF
Doctor J. Galo (Washington, DC, US)
Abstract Slides
Presentation thumbnail
Ivabradine improves win ratios of outcomes in HFrEF patients
Associate Professor A. Abdin (Homburg, DE)
Abstract Slides Video
Presentation thumbnail
Association of atrial fibrillation with heart failure measurements of the HeartLogic multi-sensor remote monitoring algorithm: data from the DANLOGIC-HF trial
Doctor F. Fussing (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Perception versus perception decoded using a pan indian survey on the awareness and utilization of GDMT in heart failure in India
Doctor P. Jayagopal (Palakkad, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Treating heart failure

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes and latent risk in HFimpEF: insights from real-world data
thumbnail
Congress Presentation
Use and associations with mortality/morbidity of guideline-directed medical therapy use in heart failure with improved ejection fraction: a PS-matched analysis from the swedish heart failure registry
thumbnail
Congress Session
Insights from recent HFrEF trials 2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources